Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review

Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review

Abstract Pulmonary arterial hypertension‐targeted therapies in portopulmonary hypertension (PoPH) are scarce, let alone for patients with chronic liver failure (CLF) and hepatopulmonary syndrome (HPS). A 48‐year male was admitted to the hospital because of cirrhosis for 18 years, systemic oedema, an...

Full description

Bibliographic Details
Main Authors: Niuniu Li, Qiang Wu, Juan Meng, Cheng Feng, Siwei Jiang, Meixia Chen, Wenhui Xu, Fei Wang, Yifan Zhang, Juncai Liu, Cheng Xu, Gaolin Liu, Hong Gao
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:ESC Heart Failure
Subjects:
Hepatopulmonary syndrome
Liver failure
Macitentan
Portopulmonary hypertension
Online Access:https://doi.org/10.1002/ehf2.14431

Internet

https://doi.org/10.1002/ehf2.14431

Similar Items